[1]
Budiarti, N. et al. 2026. Understanding the Safety Profile of Imatinib in Asian Chronic Myeloid Leukemia Patients: A Systematic Review. Jurnal Ilmiah Medicamento. 12, 1 (Mar. 2026), 2–14. DOI:https://doi.org/10.36733/medicamento.v12i1.13296.